• SPX
  • 6086.49
  • 0.61 %
  • 36.6103
  • DJI
  • 45014.04
  • 0.69 %
  • 308.5078
  • N225
  • 39488.46
  • 0.54 %
  • 212.29
  • FTSE
  • 8335.81
  • -0.28 %
  • -23.6006
  • IXIC
  • 19735.115
  • 1.3 %
  • 254.2051
Pear Therapeutics, Inc. (PEAR) Earning

Pear Therapeutics, Inc. (PEAR) Earning

NASDAQ Currency in USD Disclaimer

Stock Price
Day's range
$0.03
Day's range
$0.04

Pear Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
03/31/2023 Q4 2022 -$0.22 $0.21 0.43 $2.57 M
11/14/2022 Q3 2022 -$0.21 -$0.25 -0.04 $4.08 M
08/11/2022 Q2 2022 -$0.25 $0.30 0.55 $3.30 M
05/16/2022 Q1 2022 -$0.24 -$0.09 0.15 $2.75 M
03/28/2022 Q4 2021 -$0.67 $4.21 M
11/04/2021 Q3 2021 $0.21 $0
08/19/2021 Q2 2021 -$0.34 $0
05/24/2021 Q1 2021 $0.07 $0
 

Pear Therapeutics, Inc. Earnings: Frequently Asked Questions

  • When is Pear Therapeutics, Inc.'s earnings date?

    Pear Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 9th, 2023 based off last year's report dates.

  • Did Pear Therapeutics, Inc. beat their earnings estimates last quarter?

    In the previous quarter, Pear Therapeutics, Inc. (:PEAR) reported $0.2078 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.4278.

  • How can I listen to Pear Therapeutics, Inc.'s earnings conference call?

    The conference call for Pear Therapeutics, Inc.'s latest earnings report can be listened to online.

  • How can I read Pear Therapeutics, Inc.'s conference call transcript?

    The conference call transcript for Pear Therapeutics, Inc.'s latest earnings report can be read online.

  • How much revenue does Pear Therapeutics, Inc. generate each year?

    Pear Therapeutics, Inc. (:PEAR) has a recorded annual revenue of $12.69 M.

  • How much profit does Pear Therapeutics, Inc. generate each year?

    Pear Therapeutics, Inc. (:PEAR) has a recorded net income of $12.69 M. Pear Therapeutics, Inc. has generated $-0.17 earnings per share over the last four quarters.

  • What is Pear Therapeutics, Inc.'s price-to-earnings ratio?

    Pear Therapeutics, Inc. (:PEAR) has a price-to-earnings ratio of -0.17 and price/earnings-to-growth ratio is -0.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.